Showing results (1-10 of 697) with videos related to
Sort By:
Pageof 70
Annals of Epidemiology|July 1, 1992
On the role of coagulation and fibrinolysis in atherosclerosisI Juhan-Vague, D CollenThe Journal of Laboratory and Clinical Medicine|February 1, 1983
Complexes between tissue-type plasminogen activator and proteinase inhibitors in human plasma, identified with an immunoradiometric assayD C Rijken, I Juhan-Vague, D CollenThrombosis Research|May 15, 1991
Molecular forms of plasminogen activator inhibitor-1 (PAI-1) and tissue-type plasminogen activator (t-PA) in human plasmaM C Alessi, I Juhan-Vague, P J Declerck, et al.The Journal of Laboratory and Clinical Medicine|February 1, 1983
Measurement of human tissue-type plasminogen activator by a two-site immunoradiometric assayD C Rijken, I Juhan-Vague, F de Cock, et al.Thrombosis Research|March 1, 1984
Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditionsI Juhan-Vague, B Moerman, F De Cock, et al.Thrombosis and Haemostasis|December 22, 1988
Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2M C Alessi, I Juhan-Vague, T Kooistra, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|September 1, 1992
[Atheroma and antithrombotic agents]I Juhan-VagueJournal of Thrombosis and Haemostasis : JTH|June 11, 2005
On the role of plasminogen activator inhibitor-1 in adipose tissue development and insulin resistance in miceH R Lijnen, M-C Alessi, B Van Hoef, et al.Thrombosis and Haemostasis|February 28, 1984
Effect of 24 hours of normoglycaemia on tissue-type plasminogen activator plasma levels in insulin-dependent diabetesI Juhan-Vague, P Vague, C Poisson, et al.Thrombosis and Haemostasis|October 28, 1987
Potentiation by heparin fragments of thrombolysis induced with human tissue-type plasminogen activator or human single-chain urokinase-type plasminogen activatorJ M Stassen, I Juhan-Vague, M C Alessi, et al.Pageof 70